The present invention relates to compounds which modulate the activity of the S1P1 receptor, the use of these compounds for treating conditions associated with signaling through the S1P1 receptor, and pharmaceutical compositions comprising these compounds.

 
Web www.patentalert.com

< Benzazole analogues and uses thereof

< Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as amyotrophic lateral sclerosis (ALS), by using a HDAC inhibiting agent

> Novel compounds

> Thiol-based NAALADase inhibitors
~ 00272